Neuright, Inc., a University of Maine biotech spinout focused on the early diagnosis and treatment of peripheral neuropathy, has been awarded $225,000 under the National Science Foundation’s Small Business Technology Transfer (STTR) program to further develop its technology for delivery to market. Peripheral neuropathy, a condition in which nerve fibers die back from the skin, read more UMaine spinout Neuright receives $225,000 NSF Small Business Technology Transfer award